Australia streamlines AE drug reporting with international E2B standard
This article was originally published in SRA
Executive Summary
Australia’s Therapeutic Goods Administration has made it easier for drug companies to submit adverse event (AE) reports on medicines to the agency by giving them the option of using the international E2B standard to electronically transfer safety data1.